Literature DB >> 15591233

Role of Toll-like receptors in atherosclerosis.

Kathrin S Michelsen, Terence M Doherty, Prediman K Shah, Moshe Arditi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15591233

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

Review 1.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

Review 2.  Role of lipotoxicity in endothelial dysfunction.

Authors:  Jeong-a Kim; Monica Montagnani; Sruti Chandrasekran; Michael J Quon
Journal:  Heart Fail Clin       Date:  2012-08-10       Impact factor: 3.179

3.  Modulation of atherosclerosis in mice by Toll-like receptor 2.

Authors:  Adam E Mullick; Peter S Tobias; Linda K Curtiss
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

4.  Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.

Authors:  Prakash Doddapattar; Chintan Gandhi; Prem Prakash; Nirav Dhanesha; Isabella M Grumbach; Michael E Dailey; Steven R Lentz; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-01       Impact factor: 8.311

5.  Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.

Authors:  Takanari Miyamoto; Hiromichi Yumoto; Yusuke Takahashi; Michael Davey; Frank C Gibson; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study.

Authors:  Suthesh Sivapalaratnam; Rosienne Farrugia; Max Nieuwdorp; Cordelia F Langford; Rachel T van Beem; Stephanie Maiwald; Jaap Jan Zwaginga; Arief Gusnanto; Nicholas A Watkins; Mieke D Trip; Willem H Ouwehand
Journal:  BMC Med Genomics       Date:  2011-08-10       Impact factor: 3.063

Review 7.  Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases.

Authors:  Carlos G Leon; Rita Tory; Jessica Jia; Olena Sivak; Kishor M Wasan
Journal:  Pharm Res       Date:  2008-05-21       Impact factor: 4.200

8.  Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathway.

Authors:  Hong Luo; Jing Wang; Chenhui Qiao; Ning Ma; Donghai Liu; Weihua Zhang
Journal:  Exp Mol Med       Date:  2015-10-23       Impact factor: 8.718

9.  Side Effects of Coronary Stenting such as Severe Coronary Stenosis and Multiple Coronary Chronic Total Occlusions in Elderly Patients via Induced Proinflammatory and Prooxidative Stress.

Authors:  Xia Li; Dianxuan Guo; Hualan Zhou; Youdong Hu; Xiang Fang; Ying Chen; Fenglin Zhang
Journal:  Mediators Inflamm       Date:  2019-11-03       Impact factor: 4.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.